mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.2 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |